Ann: Positive AZD0466 clinical data presented by AstraZeneca, page-31

AZ are running this trial, not SPL. JF can only twiddle her thumbs while AZ shift into third gear by opening up a lot of trial locations worldwide (which the DEP trials failed to do) because AZ have lots of experience, staff and money. They can see another pot of gold in front of them and they will shift into fifth gear when phase 2 commences.
This drug will be available in 2024, IMHO. Remember, SPL have no input. They have done their bit and now all they can do is wait for compensation for their (critical) contribution.